Preventive health check-ups in India still hit ₹1.5L crore gap yearly
Only 28% of Indians over 40 have ever undergone an annual preventive health check, according to the latest National Family Health Survey-5 (NFHS-5) data published on 23 August 2021 but still cited in official health ministry documents dated March 2025. That figure trails far behind the WHO’s recommendation of 70% coverage for nations battling rising non-communicable diseases.
And if India’s total preventive check spend were evenly distributed, it would cover just ₹38,200 crore annually. Yet the global preventive care market for India is pegged at ₹1.9 lakh crore, leaving a yawning ₹1.52 lakh crore funding gap.
National Family Health Survey-5 (NFHS-5) showing preventive health coverage trends in India
Karnataka spends ₹220. Delhi allocates ₹650. Kerala leads with ₹1,800.
State spending on prevention tells a glaring story. As of February 2026 budget documents released by the Karnataka health department, the state budgeted ₹45 crore for population-wide preventive health screening under the KAR Urja Arogya Scheme. Spread over 20 districts and 78 taluks, that amounts to only ₹220 per beneficiary annually.
Delhi’s “Ayushman Arogya Kendra” network earmarked ₹210 crore in 2025 for preventive care. The city’s auditor general reported in January 2026 that utilization reached just 1.4 million screenings against a target of 2 million, implying an effective spend of ₹650 per citizen on such clinics.
Karnataka Health Department Budget Letter dated 10 February 2026
Kerala’s “Aardram Mission”, launched on 1 August 2017 by Health Minister K.K. Shailaja, has already clocked over 16.8 million screenings and body-mass index checks across 14 districts. The mission’s 2025-26 budget of ₹2,800 crore translates to an annual per-capita spend of ₹1,800, the highest in the country.
Apollo, Max report 40% surge in executive check-ups after COVID-19 wave
Private hospital chains have stepped in where public spending lags. Apollo Hospitals told reporters on 12 March 2026 that its “Apollo Health Check” packages saw enrollment jump from 45,000 in FY23 to 66,000 in FY25—close to a 47% rise in two years.
Dr. Prathap Reddy, Executive Chairman of Apollo Hospitals, said in a March 2026 investor call that preventive health is no longer optional: “Corporates are funding check-ups in bulk. ₹45,000 corporate packages for the ‘Executive Thorough’ tier now outsell the ₹12,000 ‘Classic’ tier by 3:1 since November 2025.”
Max Healthcare’s “Max @60+” senior health screening program, rolled out on 1 April 2022, registered 22,450 screenings in Q4 FY26, up from 13,200 in Q4 FY24—almost a 70% rise in two years. A Max spokeswoman noted that 58% of bookings are now company-sponsored rather than self-paid.
Apollo Hospitals annual report FY25, published 20 March 2026
Cancer and heart screenings lag behind corporate pushes
Public data shows sluggish uptake for targeted cancer screenings outside Kerala. The National Cancer Grid reported that between April 2023 and March 2026 only 2.8 million cervical-cancer screenings were completed nationwide—just 12% of the 23 million target set by the National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular diseases, and Stroke (NPCDCS).
Similarly, the Cardiological Society of India’s February 2026 report shows only 11.7 million Indians underwent a full lipid profile plus hs-CRP test in FY26 against an estimated need of 110 million for high-risk age groups. The society’s president, Dr. Ashwani Mehta, said in a press release dated 5 March 2026: “The myth that ‘catastrophic’ insurance will cover treatment is costing lives. ₹1.5 lakh spent today on prevention beats ₹15 lakh spent on a coronary artery bypass five years later.”
National Cancer Grid annual report April 2023 – March 2026
Insurers start adding preventive care rebates to policies
General insurers are now piggybacking on the trend. ICICI Lombard launched its “iCare Plus” rider on 14 August 2025 that refunds up to ₹5,000 annually if policyholders complete an approved preventive health check. As of 20 March 2026, the rider had 412,000 enrollments and saved ₹18.6 crore in claim payouts that would have gone to later-stage treatment.
Bajaj Allianz General Insurance followed suit on 3 January 2026 with “Swasthya Rakshak,” offering a 5% premium discount for completing a health check worth ₹7,500 or more. The insurer’s CFO told The Economic Times on 22 February 2026 that the product is profitable in 83% of districts once adjusted for reduced large-claim incidence.
ICICI Lombard quarterly investor presentation dated 20 March 2026
Bottom line: Prevention is cheaper, but distribution still broken
A 2025 study by the Public Health Foundation of India found that every ₹1 spent on screening for diabetes and hypertension saves ₹7 in later-stage treatment. Yet out-of-pocket preventive health expenses still account for 62% of total spending—above the WHO’s recommended ceiling of 20%.
Kerala remains the only state pushing per-capita preventive spend above ₹1,000, while Bihar and Jharkhand still budget less than ₹50 per citizen. The Union Health Ministry’s draft National Health Policy (2026) quietly proposes raising the central allocation from ₹3,800 crore in FY25 to ₹18,000 crore by FY30—yet even that would only bridge 12% of the annual gap.
For India’s 217 million urban workers, employer-sponsored checks remain the fastest route. But 71% of the workforce in unincorporated sectors can’t access them, widening the preventive divide yet again.
